EBM Newsletter by Xagena – Evidence-based Medicine
Evidence-based Medicine
EBM, una branca della Medicina che si propone di facilitare le decisioni diagnostiche e terapeutiche, con risvolti anche nella gestione delle risorse economiche
–
High-dose fish oil does not reduce atrial fibrillation recurrence, inflammation, and oxidative stress
Recent trials of fish oil for the prevention of atrial fibrillation ( AF ) recurrence have provided mixed results. Notable uncertainties in the existing evidence base include the roles of high-dose fi …
ST-segment elevation myocardial infarction: efficacy of MGuard, an embolic protection stent as a function of delay to reperfusion
The ability of stent implantation to improve indexes of reperfusion may depend on the time to reperfusion in acute ST-segment elevation myocardial infarction ( STEMI ) and may also vary with stent typ …
Cardiac resynchronisation therapy for the treatment of heart failure and ICD for the treatment of arrhythmias: assessment of clinical effectiveness and cost-effectiveness
This assessment updates and expands on two previous technology assessments that evaluated implantable cardioverter defibrillators ( ICDs ) for arrhythmias and cardiac resynchronisation therapy ( CRT ) …
Per iscriversi alla Newsletter Evidence Medicine in inglese
Coloro che sono GIA’ ISCRITTI ad altre Newsletter Xagena possono accedere al Pannello di Controllo al sito XagenaWeb.it inserendo l’indirizzo e-mail con il quale ricevono le Newsletter e la Password personale [ RIPORTATA IN FONDO A OGNI NEWSLETTER ] E’ importante confermare la modifica cliccando sul tasto SALVA MODIFICA